As of May 22
| +0.10 / +0.95%|
The 5 analysts offering 12-month price forecasts for Sucampo Pharmaceuticals Inc have a median target of 19.00, with a high estimate of 28.50 and a low estimate of 11.00. The median estimate represents a +78.40% increase from the last price of 10.65.
The current consensus among 5 polled investment analysts is to Buy stock in Sucampo Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.